BUZZ-Twist Bioscience dips after starting $250 mln stock offering
TWST•Share count, market cap and recent performance
South San Francisco, California-based firm has about 62.7 mln shares outstanding for about a $6.2 bln market cap.
The stock finished down 1.6% at $99.44, but has more than tripled year to date.
The average rating of 10 analysts is "buy"; median price target is $112, per LSEG data.
Twist Bioscience starts $250 million stock offering
Biotech firm Twist Bioscience's TWST.O shares dip 1.1% to $98.38 post-market after equity raise news.
TWST commences a $250 mln stock offering.
The company intends to use net offering proceeds for R&D, expansion of manufacturing capacity, product offerings, with the remainder for other purposes.
Goldman Sachs, William Blair, Leerink and Guggenheim are joint bookrunners.
